CD4 and non-small cell lung carcinoma: This is consistent with a report showing that CD4+CD161+ TIL in NSCLC are more activated.43 These findings suggest that CD161 is a marker of a specific activation state of CD4+ cells in which cells are more prone to produce type 1 cytokines upon low-dose antigen encounter.